APA

Jacobs S., Fox E., Krailo M., Hartley G., Navid F., Wexler L., Blaney S. M., Goodwin A., Goodspeed W., Balis F. M., Adamson P. C. & Widemann B. C. (20100412). Phase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: a report from the children's oncology group. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Jacobs Shana, Fox Elizabeth, Krailo Mark, Hartley Gwen, Navid Fariba, Wexler Leonard, Blaney Susan M, Goodwin Anne, Goodspeed Wendy, Balis Frank M, Adamson Peter C and Widemann Brigitte C. 20100412. Phase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: a report from the children's oncology group. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Jacobs S., Fox E., Krailo M., Hartley G., Navid F., Wexler L., Blaney S. M., Goodwin A., Goodspeed W., Balis F. M., Adamson P. C. and Widemann B. C. (20100412). Phase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: a report from the children's oncology group. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Jacobs Shana, Fox Elizabeth, Krailo Mark, Hartley Gwen, Navid Fariba, Wexler Leonard, Blaney Susan M, Goodwin Anne, Goodspeed Wendy, Balis Frank M, Adamson Peter C and Widemann Brigitte C. Phase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: a report from the children's oncology group. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20100412.